Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-445-8110Fax+1 216-445-6259
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1980 - 1987
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
Certifications & Licensure
OH State Medical License 1994 - 2025
PA State Medical License 1982 - 1994- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- AVONEX® Combination Trial - "ACT" Start of enrollment: 2003 Jun 01
- Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS Start of enrollment: 2011 Mar 01
- Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Publications & Presentations
PubMed
- Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri) Dosing: NOVA Phase IIIb Extension Study (Part 2).Heinz Wiendl, John Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen
Neurology and Therapy. 2024-10-01 - Differential diagnosis of suspected multiple sclerosis: global health considerations.Jorge Correale, Andrew J Solomon, Jeffrey A Cohen, Brenda L Banwell, Fernando Gracia
The Lancet. Neurology. 2024-10-01 - 1 citationsDifferential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Aus...Lilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, Olga Ciccarelli, Daniel Ontaneda
The Lancet. Neurology. 2024-10-01
Press Mentions
- Long-Term Ocrelizumab Shows Benefit in Progressive MSNovember 3rd, 2020
- Long-Term Ocrelizumab Benefits Seen in PPMSNovember 2nd, 2020
Pregnant Women with MS Show Increased NfLSeptember 28th, 2020- Join now to see all
Professional Memberships
- Member
External Links
- Cleveland Clinichttp://my.clevelandclinic.org/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
